Carbohydrate metabolism pathway

The "Carbohydrate metabolism pathway" refers to a collection of interconnected biochemical processes responsible for breaking down carbohydrates—primarily glucose—to generate energy, reducing equivalents, and biosynthetic precursors necessary for cell survival and proliferation. This includes glycolysis, gluconeogenesis, glycogenolysis, glycogenesis, the pentose phosphate pathway, and related cycles. In cancer biology specifically, altered carbohydrate metabolism supports rapid tumor growth through increased glucose uptake ("Warburg effect") and reprogrammed flux through these pathways[1][2]. While numerous drugs target key enzymes or transporters involved in these processes—such as GLUT inhibitors like WZB117 or Glutor targeting glucose transporters—the "carbohydrate metabolism pathway" itself is not a single molecular entity but rather an umbrella term encompassing many potential therapeutic targets[2]. Therefore it is not considered a canonical drug target but rather describes multiple possible intervention points within cellular biochemistry. Note: The entry "Carbohydrate metabolism pathway" does not refer to a discrete molecule/receptor/protein but instead denotes an entire class of biochemical reactions involving many different proteins. For structured data purposes it should be flagged as incorrect/not suitable as a canonical drug target name. Individual components such as "Glucose transporter 1" or "Hexokinase 2" are valid targets within this broader context[4].

Other names

Carbohydrate metabolic pathwayGlucose metabolism pathwayCentral carbon metabolism (context-dependent)